Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results

[PR Newswire] – TARRYTOWN, N.Y., Feb. 11, 2014 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced financial results for the fourth quarter and full year 2013 and provided an update on development … more

View todays social media effects on REGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Regeneron is hiring next, click here to view